Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,562.00    -198.00 (-5.27%)
Bid:
3,562.00
Ask:
3,422.00
Spread: -140.00 (-3.93%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

COVID-19 Update

19 Mar 2020 07:00

RNS Number : 6978G
4imprint Group PLC
19 March 2020
 

19 March 2020

 

4imprint Group plc ("4imprint" or the "Group")

Coronavirus (COVID-19): Update

 

In the light of the rapidly evolving situation resulting from the spread of COVID-19 and its development into a global pandemic, 4imprint today provides an update on the Group's current trading and operations.

 

Our first priority remains the health, safety and well-being of our people. This will not change. We will be informed by the latest governmental recommendations and measures and we will play our part to control the spread of COVID-19.

 

COVID-19 poses two primary threats to our business operations:

· Supply chain disruption. As noted in the Group's 2019 full year results announcement on 3 March 2020, around 60% of the blank products that we sell originate in China. In February 2020, at the height of the COVID-19 disruption in China, this part of the supply chain was a major concern. However, the timing of the inventory cycle meant that our domestic suppliers have been able to fulfil our customer orders since then. At the same time, we have closely monitored a substantial recovery of production capacity in Chinese factories. A more pressing supply concern now is the spread of COVID-19 in North America and the UK and the resulting potential restrictions on the operations of our domestic suppliers. We have very strong relationships with our suppliers and we will continue to work closely with them in the coming days and weeks as the situation evolves.

· Demand implications of global pandemic. The rapid spread of COVID-19 in North America and the UK has now begun to have a serious impact on demand in our business. In our results announcement on 3 March 2020, we noted that trading results in the first two months of 2020 were in line with the Board's expectations. To be more specific, total orders received were up more than 13% over the same period in 2019, and this level of demand activity continued through 9 March 2020. From 10 March 2020 onwards, however, we have experienced a significant reduction in daily order flow. Over this short space of time, daily order counts have been very volatile, and have fallen materially to an average over the last three trading days of around 40% of the prior year.

 

We are unable to predict how long this lower level of order activity will last, but clearly the effects of COVID-19 will impact revenue and profitability in the current financial year. In the immediate term we are materially recalibrating our marketing activities and identifying and implementing cost saving initiatives, whilst being careful not to compromise the long-term prospects of the business. We have every confidence in the flexibility and professionalism of our team members to look after our customers at this difficult time.

 

There is no historical precedent in the business for the demand reduction that we are seeing. At this point the speed and volatility of the unfolding crisis makes accurate or responsible forecasting very challenging. We are, however, actively working through models at various levels of demand and duration that will help guide our decision making. Additional guidance will be provided to the market as and when we have more clarity.

 

4imprint remains very well-financed, with a $51m cash balance at the end of February 2020 and no debt. Given the strength and market position of the business prior to the COVID-19 crisis, the Board remains confident in the ability of the team to manage the business successfully through difficult times and to protect longer-term value for all stakeholders.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/ 2014. The person who arranged the release of this announcement on behalf of 4imprint was David Seekings, Chief Financial Officer of 4imprint.

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

MHP Communications

Tel. + 44 (0) 20 3128 8100

 

Kevin Lyons-Tarr

Chief Executive Officer

 

David Seekings

Chief Financial Officer

Katie Hunt

 

 

Rachel Mann

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFDFWAESSESD
Date   Source Headline
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase
2nd Sep 20249:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.